Trials / Unknown
UnknownNCT03831698
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study aimed at assessing the effects of moderate dose omega-3-acid ethyl esters capsules (generic Lovaza) on molecular, and intestinal microbiota changes in participants at high risk for colorectal cancer. The study will be a single arm, open label study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega-3 fatty acid ethyl esters (2 gram) | Omega-3 fatty acid ethyl esters (2 gram) |
Timeline
- Start date
- 2019-02-06
- Primary completion
- 2022-06-08
- Completion
- 2024-08-01
- First posted
- 2019-02-06
- Last updated
- 2023-06-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03831698. Inclusion in this directory is not an endorsement.